4-bromo-7-hydroxyindan oxime--a new potent spermicidal agent

Area of Science:

• Reproductive biology
• Toxicology
• Medicinal chemistry

Background:

• Spermicides are crucial for reproductive health and family planning.
• Novel spermicidal agents require rigorous evaluation for efficacy and safety.
• Chelating agents represent a potential class of compounds for spermicidal applications.

Purpose of the Study:

• To evaluate the in vitro spermicidal efficacy of eleven ring-structured chelating agents.
• To identify the most potent and least toxic spermicidal agent among the tested compounds.
• To assess the in vivo safety profile of the lead spermicidal candidate in a mammalian model.

Main Methods:

• In vitro assessment of spermicidal activity using human spermatozoa.
• Determination of the lowest effective concentration (LEC) for sperm immobilization.
• Acute toxicity testing (LD50) and local irritation studies in rabbits.
• Subchronic vaginal administration and reproductive toxicity studies in rabbits.

Main Results:

• All eleven chelating agents exhibited potent in vitro spermicidal activity.
• 4-Bromo-7-hydroxyindan oxime (S-11) was identified as the most potent spermicide (LEC: 0.02 mg/ml).
• S-11 demonstrated the lowest toxicity (acute LD50: 2936 mg/kg) and no local irritation or systemic/reproductive toxicity in rabbits.

Conclusions:

• 4-Bromo-7-hydroxyindan oxime (S-11) is a highly effective and safe spermicidal agent.
• S-11 shows promise as a novel contraceptive agent with a favorable safety profile.
• Further research into S-11 for contraceptive development is warranted.